Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

7 results
Display

Indoxyl sulfate, homocysteine, and antioxidant capacities in patients at different stages of chronic kidney disease

Chen CH, Huang SC, Yeh EL, Lin PC, Tsai SF, Huang YC

BACKGROUND/OBJECTIVES: Increased levels of uremic toxins and decreased antioxidant capacity have a significant impact on the progression of chronic kidney disease (CKD). However, it remains unclear whether they interact with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Multislice CT Scans in Patients on Extracorporeal Membrane Oxygenation: Emphasis on Hemodynamic Changes and Imaging Pitfalls

Liu KL, Wang YF, Chang YC, Huang SC, Chen SJ, Tsang YM, Chang CC

This pictorial review provides the principles of extracorporeal membrane oxygenation (ECMO) support and associated CT imaging features with emphasis on the hemodynamic changes and possible imaging pitfalls encountered. It is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Chronic hepatitis B with concurrent metabolic dysfunction-associated fatty liver disease: Challenges and perspectives

Huang SC, Liu CJ

The prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) has increased among the general population and chronic hepatitis B (CHB) patients worldwide. Although fatty liver disease is a well-known risk...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Risk of Hepatitis B Virus (HBV) Reactivation in HBsAg-Negative, Anti-HBc-Negative Patients Receiving Rituximab for Autoimmune Diseases in HBV Endemic Areas

Lan TY, Lin YC, Tseng TC, Yang HC, Kao JH, Cheng CF, Lee TJ, Huang SC, Lu CH, Li KJ, Hsieh SC

Background/Aims: Rituximab is known to be associated with high hepatitis B virus (HBV) reactivation rate in patients with resolved HBV infection and hematologic malignancy. However, data regarding HBV reactivation (HBVr) in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Huang SC, Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, Liu CJ

Background/Aims: Fatty liver disease is defined as a cluster of diseases with heterogeneous etiologies, and its definition continues to evolve. The novel conceptional criteria for metabolic dysfunction-associated fatty liver disease...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Direct comparison of biopsy techniques for hepatic malignancies

Huang SC, Liang JD, Hsu SJ, Hong TC, Yang HC, Kao JH

Background/Aims: The core needle biopsy (CNB), fine needle aspiration cytology (FNAC) and touch imprint cytology (TIC) are commonly used tools for the diagnosis of hepatic malignancies. However, little is known...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation

Lin WC, Chen WC, Wang PW, Chan YC, Chang YH, Chen HS, Chen ST, Chen WC, Cheng KL, Chi SY, Chiang PL, Chou CK, Chou FF, Huang SC, Liu FH, Luo SD, Tseng FY, Wang CY, Wang WH, Wu MH

Radiofrequency ablation (RFA) is a minimally invasive management strategy that has been widely applied for benign and recurrent malignant thyroid lesions as an alternative to surgery in Taiwan. Members of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr